These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y. PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248 [Abstract] [Full Text] [Related]
3. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy. Murakoshi M, Gohda T, Sonoda Y, Suzuki H, Tomino Y, Horikoshi S, Suzuki Y. Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814 [Abstract] [Full Text] [Related]
5. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy. Li XH, Huang XP, Pan L, Wang CY, Qin J, Nong FW, Luo YZ, Wu Y, Huang YM, Peng X, Yang ZH, Liao YH. BMC Nephrol; 2016 Nov 02; 17(1):164. PubMed ID: 27806690 [Abstract] [Full Text] [Related]
6. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy. Fernández-Juárez G, Villacorta Perez J, Luño Fernández JL, Martinez-Martinez E, Cachofeiro V, Barrio Lucia V, Tato Ribera AM, Mendez Abreu A, Cordon A, Oliva Dominguez JA, Praga Terente M. Nephrology (Carlton); 2017 May 02; 22(5):354-360. PubMed ID: 27003829 [Abstract] [Full Text] [Related]
8. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function. Gohda T, Kamei N, Kubota M, Tanaka K, Yamashita Y, Sakuma H, Kishida C, Adachi E, Koshida T, Murakoshi M, Hagiwara S, Funabiki K, Ueda S, Suzuki Y. J Diabetes Investig; 2021 Mar 02; 12(3):382-389. PubMed ID: 32643269 [Abstract] [Full Text] [Related]
10. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity. Miedziaszczyk M, Oko A, Wolc A, Woźniak A, Idasiak-Piechocka I. Adv Clin Exp Med; 2024 Jun 02; 33(6):583-591. PubMed ID: 37962255 [Abstract] [Full Text] [Related]
12. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Idasiak-Piechocka I, Oko A, Pawliczak E, Kaczmarek E, Czekalski S. Nephrol Dial Transplant; 2010 Dec 02; 25(12):3948-56. PubMed ID: 20525973 [Abstract] [Full Text] [Related]
16. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy. Oh HJ, Ahn SV, Yoo DE, Kim SJ, Shin DH, Lee MJ, Kim HR, Park JT, Yoo TH, Kang SW, Choi KH, Han SH. Kidney Int; 2012 Dec 02; 82(12):1304-12. PubMed ID: 22895518 [Abstract] [Full Text] [Related]
18. CD147 renal expression as a biomarker for progressive IgAN. Sun S, Zhao A, Li R, Du R, He L, Sun W, Wang H, Huang C. J Nephrol; 2015 Jun 02; 28(3):307-14. PubMed ID: 25510296 [Abstract] [Full Text] [Related]
19. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Nephrol Dial Transplant; 2009 Dec 02; 24(12):3694-701. PubMed ID: 19628647 [Abstract] [Full Text] [Related]
20. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Nephrol Dial Transplant; 2012 Apr 02; 27(4):1479-85. PubMed ID: 21965586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]